| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Novocure Limited (NVCR) has 8 insiders with recent SEC Form 4 filings, including 0 buys and 24 sells. NVCR is classified in the Health Care Equipment & Supplies industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 437.6K | $5.96M | - | |
| Dir | 416.5K | $5.67M | - | |
| VP | 347.7K | $4.73M | - | |
| Other | 174.5K | $2.37M | - | |
| Other | 163.8K | $2.23M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2022 | Groenhuysen Wilhelmus Cm65 | Chief Operating Officer | Sell | 296 | $79.04 | $23,394.95 | -0.2% | +3.7% | -71.7% | |
| Sep 2, 2022 | Shah Pritesh75 | Chief Commercial Officer | Sell | 269 | $79.04 | $21,260.95 | -0.3% | +3.7% | -71.7% | |
| Sep 2, 2022 | Leonard Frank X76 | Chief Development Officer | Sell | 14,796 | $77.50 | $1,146,633.76 | -1.2% | +3.7% | -71.7% | |
| Aug 3, 2022 | Benaim Ely73 | Chief Medical Officer | Sell | 5,959 | $73.73 | $439,327.67 | -8.7% | +0.7% | -60.0% | |
| Aug 2, 2022 | Doyle William F53 | Executive Chairman | Sell | 837 | $69.66 | $58,304.58 | -0.2% | +0.7% | -57.1% | |
| Aug 2, 2022 | Benaim Ely73 | Chief Medical Officer | Sell | 437 | $69.66 | $30,440.98 | -1.2% | +0.7% | -57.1% | |
| Aug 2, 2022 | Leonard Frank X76 | Chief Development Officer | Sell | 414 | $69.66 | $28,838.83 | -0.4% | +0.7% | -57.1% | |
| Jun 10, 2022 | Hilleman Jeryl L61 | Director | Sell | 407 | $69.61 | $28,331.27 | -13.8% | +25.0% | -38.4% | |
| May 11, 2022 | Benaim Ely73 | Chief Medical Officer | Sell | 4,205 | $63.17 | $265,645.81 | -5.5% | +32.5% | +26.3% | |
| Mar 9, 2022 | Shah Pritesh75 | Chief Commercial Officer | Sale+OE | 3,669 | $71.19 | $261,196.11 | -4.2% | +9.7% | -1.2% |